Results 141 to 150 of about 170,400 (293)
Objective To evaluate the real‐world safety and efficacy for standard surgical risk patients with extracranial internal carotid artery disease undergoing transcarotid artery revascularization. Methods ROADSTER 3 is a prospective, multicenter, single‐arm post‐approval study.
Jeffrey Jim +15 more
wiley +1 more source
Cytoprotective effect of prostacyclin on hepatic ischemia-reperfusion injury. [PDF]
Mouratidou C +9 more
europepmc +1 more source
Retraction for Zimmerman et al., Signaling through hepatocellular A2B adenosine receptors dampens ischemia and reperfusion injury of the liver [PDF]
Michael Zimmerman +6 more
openalex +1 more source
Among patients with acute ischemic stroke achieving successful large vessel recanalization (defined as expanded Thrombolysis in Cerebral Infarction [eTICI ≥2b]), incomplete tissue‐level reperfusion, distinct from visually identifiable distal occlusion on digital‐subtraction angiography, remains a significant challenge.
Yue Qiao +4 more
wiley +1 more source
Modified mRNA-Based Therapeutic Strategies for Myocardial Ischemia-Reperfusion Injury. [PDF]
Cai T, Yang XQ.
europepmc +1 more source
Phytic acid exerts protective effects in cerebral ischemia-reperfusion injury by activating the anti-oxidative protein sestrin2 [PDF]
Jing Liu +6 more
openalex +1 more source
Objective Immunothrombosis contributes to ischemic stroke pathophysiology through neutrophil extracellular trap (NET) formation, which promotes thrombus stabilization and microvascular dysfunction. DNase1 is the principal endonuclease responsible for NET degradation.
B. Díaz‐Benito +10 more
wiley +1 more source
Role of Sulfide Quinone Oxidoreductase and Supersulfides in Hepatic Ischemia-Reperfusion Injury in Mice. [PDF]
Takamori S +11 more
europepmc +1 more source

